Integrated Biopharma Inc. Reports Fiscal 2026 Financial Results

What Happened

• Integrated Biopharma, Inc. (INBP) filed a Form 8-K on September 25, 2026, announcing it issued a press release reporting its financial results for the fiscal period ended June 30, 2026.
• The press release is furnished as Exhibit 99.1 to the 8-K and is incorporated by reference into the filing.

Key Details

• Filing date: September 25, 2026 (Form 8-K, Item 2.02 — Results of Operations and Financial Condition).
• Reporting period: fiscal period ended June 30, 2026.
• Press release provided as Exhibit 99.1 and incorporated by reference.

Why It Matters

• This 8-K notifies investors that Integrated Biopharma has publicly released its latest financial results (earnings, revenue and other operating metrics) for the period ended June 30, 2026.
• Investors should review the Exhibit 99.1 press release in the filing to see reported revenue, earnings (or loss), cash position and any management commentary or forward-looking statements that could affect near-term valuation and trading decisions.